Picture of DXS International logo

DXSP — DXS International News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Statement re: Further NHS Accreditation

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230425:nGNE7xpQlK&default-theme=true


DXS INTERNATIONAL PLC

(AQSE: DXSP)

Statement Re:  Further NHS Accreditation

DXS International, the digital clinical decision support company, is pleased
to announce that on Friday 14 April it received NHS Accreditation for the NHS
IM1 Pairing Integration API which provides read and write access to GP patient
data throughout the UK.

This important achievement alleviates DXS’ dependency on using the existing
commercial integrations provided by the three leading suppliers of primary
care patient record systems in the UK. The development will also significantly
enhance DXS’ ability to deliver its new ExpertCare Hypertension solution to
users such as GPs, nurses and pharmacists throughout the UK, faster, better
and more cost effectively.

This 18-month development initiative included building the foundation
component of a new cloud based Aios platform which will significantly speed up
deployment of various DXS products, automate user workflows and reduce support
overhead.

David Immelman, DXS CEO, said “This is an exciting step forward, especially
as DXS ExpertCare can help the NHS achieve its new target in England for GP
practices to get controlled blood pressure up from 60% to 77% of the 8.5
million hypertensive patients in England which can save thousands of strokes
and heart attacks.”

The Directors of DXS International plc accept responsibility for this
announcement.

Contacts:

 David Immelman (Chief Executive) DXS International plc  01252 719800 david@dxs-systems.com  
 https://www.dxs-systems.co.uk                                                               



 Corporate Advisor                              
 City & Merchant David Papworth  020 7101 7676  



 Corporate Broker                                 
 Hybridan LLP Claire Louise Noyce  020 3764 2341  

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted NHS
sources, to doctors, nurses and pharmacists in their workflow and during the
patient consultation. This effective clinical decision support ultimately
translates to improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its projected
efficiency savings

Recent news on DXS International

See all news